» Articles » PMID: 38457656

RaptGen-Assisted Generation of an RNA/DNA Hybrid Aptamer Against SARS-CoV-2 Spike Protein

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2024 Mar 8
PMID 38457656
Authors
Affiliations
Soon will be listed here.
Abstract

Optimization of aptamers in length and chemistry is crucial for industrial applications. Here, we developed aptamers against the SARS-CoV-2 spike protein and achieved optimization with a deep-learning-based algorithm, RaptGen. We conducted a primer-less SELEX against the receptor binding domain (RBD) of the spike with an RNA/DNA hybrid library, and the resulting sequences were subjected to RaptGen analysis. Based on the sequence profiling by RaptGen, a short truncation aptamer of 26 nucleotides was obtained and further optimized by a chemical modification of relevant nucleotides. The resulting aptamer is bound to RBD not only of SARS-CoV-2 wildtype but also of its variants, SARS-CoV-1, and Middle East respiratory syndrome coronavirus (MERS-CoV). We concluded that the RaptGen-assisted discovery is efficient for developing optimized aptamers.

Citing Articles

A Truncated Multi-Thiol Aptamer-Based SARS-CoV-2 Electrochemical Biosensor: Towards Variant-Specific Point-of-Care Detection with Optimized Fabrication.

Molina Ramirez S, Samiseresht N, Martinez-Roque M, Catania F, Graef K, Rabe M Biosensors (Basel). 2025; 15(1).

PMID: 39852074 PMC: 11763500. DOI: 10.3390/bios15010024.

References
1.
Sun M, Liu S, Wei X, Wan S, Huang M, Song T . Aptamer Blocking Strategy Inhibits SARS-CoV-2 Virus Infection. Angew Chem Int Ed Engl. 2021; 60(18):10266-10272. PMC: 8014204. DOI: 10.1002/anie.202100225. View

2.
Caroli J, Forcato M, Bicciato S . APTANI2: update of aptamer selection through sequence-structure analysis. Bioinformatics. 2019; 36(7):2266-2268. DOI: 10.1093/bioinformatics/btz897. View

3.
Minagawa H, Sawa H, Fujita T, Kato S, Inaguma A, Hirose M . A high-affinity aptamer with base-appended base-modified DNA bound to isolated authentic SARS-CoV-2 strains wild-type and B.1.617.2 (delta variant). Biochem Biophys Res Commun. 2022; 614:207-212. PMC: 9060713. DOI: 10.1016/j.bbrc.2022.04.071. View

4.
Walls A, Park Y, Tortorici M, Wall A, McGuire A, Veesler D . Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020; 181(2):281-292.e6. PMC: 7102599. DOI: 10.1016/j.cell.2020.02.058. View

5.
Valero J, Civit L, Dupont D, Selnihhin D, Reinert L, Idorn M . A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entry. Proc Natl Acad Sci U S A. 2021; 118(50). PMC: 8685691. DOI: 10.1073/pnas.2112942118. View